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Prescription Drug Abuse
Among Ecstasy Users in Miami
Steven P. Kurtz, PhD
James A. Inciardi, PhD
Hilary L. Surratt, MA, MPhil
Linda Cottler, PhD
ABSTRACT. This study examines the nature, extent and consequences
of prescription drug abuse among 143 ecstasy users in Miami. Partici-
pants were recruited through nightclub and college campus outreach,
and through respondent referrals. Instrumentation included the Risk Be-
havior Assessment, Substance Abuse Module and Center for Epidemio-
logical Studies Depression Scale. Median age was 23, 42% were female
and 50% Hispanic. An arrest history was reported by 44%, and 33% re-
ported prior drug/alcohol treatment. Prescription drug abuse was re-
ported by 87%; alprazolam (57%), oxycodone (36%), hydrocodone
(32%) and diazepam (30%) were cited most often. Prescription drug
abusers were more likely to report polydrug use, drug treatment histo-
ries, risky drug use behaviors, and symptoms of depression. They also
reported numerous physical, psychological and social consequences of
prescription drug abuse. Additional studies among larger samples are
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needed to understand the processes of prescription drug access and the
extent of integration in club drug using cultures. [Article copies available
for a fee from The Haworth Document Delivery Service: 1-800-HAWORTH.
E-mail address: <docdelivery@haworthpress.com> Website: <http://www.
HaworthPress.com>  2005 by The Haworth Press, Inc. All rights reserved.]
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INTRODUCTION
The non-medical use (abuse) of pharmaceuticals and prescription
drugs has been a longstanding problem in the United States. The first
general population survey of drug abuse undertaken in the U.S. was
conducted in New York State in 19701–one year before the first Na-
tional Household Survey on Drug Abuse (NHSDA). The New York
survey found the abuse of barbiturates and other sedatives, amphet-
amines and other stimulants, and other prescription drugs to be com-
monplace. Subsequent surveys as well as focused research studies
documented the continuing abuse of prescription drugs.2-6 Moreover,
from the 1970s through the 1990s, several prescription drugs cycled in
and out of the American drug scene–pentazocine (T’s & blues), meth-
aqualone (Quaalude), propoxyphene (Darvon)–while others maintained
a steady presence–diazepam (Valium), meperidine (Demerol), plus a
host of others.3,7-10 By the close of the 1990s, it had become clear from
data gathered through the Drug Abuse Warning Network (DAWN),
NIDA’s Community Epidemiology Work Group (CEWG), the Moni-
toring the Future (MTF) surveys, and the NHSDA (now referred to as
the National Survey on Drug Use and Health, or NSDUH) that prescrip-
tion drug abuse was on the upswing, and that this was particularly the
case with regard to prescription opioids.11
Independent of the growth of prescription drug abuse during the past
few decades, another significant and pervasive pattern of drug abuse
had been evolving. Since the 1970s there has been the emergence and
expansion of the so-called “club drugs” and “club culture.” Club drugs
(alternatively called “rave drugs,” “dance drugs” and “party drugs,”
among other things) is a vague term that refers to a wide variety of sub-
stances. Originally associated with “raves,” “trances,” and other all-
night dance parties, the most popular of the club drugs have been
MDMA (ecstasy), GHB, Rohypnol, ketamine, LSD, methamphetamine,
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and a few prescription drugs, such as dextroamphetamine and methyl-
phenidate.12-17 The “club culture,” on the other hand, refers to those ad-
olescents and young adults (and more recently, growing numbers of
middle-aged adults) who participate in the club drug and dance party
scenes.15,17 Since the late 1990s, as the abuse of prescription drugs be-
came more widespread, some of these drugs began to appear in small
amounts in segments of the club culture–most typically diazepam (Val-
ium), alprazolam (Xanax), hydrocodone (Vicodin), and most recently
oxycodone (Percocet, Percodan, and OxyContin®), and Viagra.18-20
Miami, Florida, historically a major tourist destination and since the
early 1970s a national hub for cocaine importation, distribution, and
use,21-23 is also a major focal point of the club drug scene. In fact, with
the restoration of Miami’s art deco districts and the large and continu-
ously expanding South Beach area, Miami has become a national and
international destination for partying, sexual tourism, and club drug use.
And to a great extent, South Beach has also become an east coast center
for the club culture–setting trends that are emulated and replicated else-
where in the United States, Western Europe, and Latin America.24-31
Miami has also been designated by the Drug Enforcement Administra-
tion (DEA) as a destination where large amounts of prescription drugs
are regularly being channeled into the illegal marketplace.32 A recent
trend in this regard has been a significant incursion of prescription drugs
into the club culture, with the concomitant health consequences associ-
ated with their abuse.
The “abuse” or “misuse” of a prescription drug has been defined in a
variety of ways, but in this report, the term “prescription drug abuse” re-
fers to the non-medical use of prescription drugs for the purposes of en-
hancing pleasure and/or performance, and/or for moderating the “highs,”
“lows,” and other effects associated with the abuse of other drugs.33 The
health consequences of prescription drug abuse have been well docu-
mented–tolerance, dependence, addiction, overdose, seizures, coma,
impairment of functioning, and death, to name but a few.11,34-40 Because
of the young age of the vast majority of club drug users and their ten-
dency to mix numerous drugs during their typical drug binges, club
drug users tend to be a highly vulnerable population.41-47 However,
there are few published scientific studies of the health and social conse-
quences of club drug use. Ecstasy has received the most attention in this
regard, with several studies reporting associations between heavy use
and chronic psychiatric symptoms, including memory problems, de-
pression, anxiety and suicidal ideation;48-52 patterns of polydrug use
among ecstasy users confound definitive conclusions, however.49 Re-
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search in the extent and consequences of prescription drug abuse among
club drug users is absent from the literature. This study makes use of
data collected from an ongoing study of the prevalence of withdrawal
and dependence symptoms associated with club drug (primarily ec-
stasy) use to examine the patterns and consequences of prescription
drug abuse among this population.
METHODS
Site
Miami-Dade County, Florida, is an extremely diverse community,
having a high population of foreign-born (45.1%) residents.53 Hispan-
ics (57.3%) are the largest ethnic group, with “Anglos” (defined locally
as non-Hispanic Whites) representing 20.7%, and Black/African-Ameri-
cans 20% of the county population. Composed of 28 independent mu-
nicipalities and a large unincorporated area, the county’s economy is
based largely upon import/export trade and tourism. The rave scene
popular during the early- and mid-1990s (usually transitory dance and
drug parties organized in rural open grounds, warehouses, and other
large little-used spaces) is no longer in evidence in Miami-Dade County.
The past decade has witnessed the expansion of real estate development
to the last westward possibilities in the county, right to the borders of the
Everglades National Park system. Police crackdowns have eliminated
the use of properties in developed areas for large raves or parties. Mi-
ami’s club drug-using scene is primarily found in an extensive network
of large and small nightclubs that are of a few recognized general types:
large dance clubs, smaller liquor-serving clubs with small dance floors,
after-hours bars that do not serve alcohol, and gay male sex clubs and
bathhouses.
Subjects/Informed Consent
The sample was recruited through outreach in nightclub districts and
educational institutions, advertisements in alternative print media, and
referrals from other study participants. At the first formal contact, call-
ers were screened to determine eligibility over the telephone. Partici-
pants were required to be at least 16 years of age (written parental
consent was required for anyone under 18), and to report using ecstasy
more than five times lifetime and at least once in the past 12 months. For
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eligible respondents, trained interviewers explained the confidential na-
ture of the study, the purpose of the study–to test the reliability of the in-
terview with a test-retest design–and the incentive payment structure
($20 for the first interview, $50 for the second, and an additional $20 if
randomized to receive an independent clinician’s assessment). Those
agreeing to participate reviewed and signed informed consent at the
time of the first interview using procedures approved by the University
of Delaware’s Institutional Review Board. Only data from participants’
first interviews are presented in this report.
Measures
Data were collected by trained interviewers using a computer-as-
sisted Washington University Risk Behavior Assessment (RBA) based
on the NIDA RBA,54 and the Substance Abuse Module (SAM)55 that
had been adapted for club drugs, as well as the manually-administered
Center for Epidemiological Studies Depression Scale (CES-D).56 The
RBA contains questions about a wide variety of drug use and sexual risk
behaviors; modifications for this study included the addition of ques-
tions about the non-medical use of prescription drugs. The SAM as-
sesses use of substances more than five times lifetime as well as criteria
for assessing abuse of and dependence on substances and categories of
substances as defined by the Diagnostic and Statistical Manual of Men-
tal Disorders–Fourth Edition (DSM-IV). It also includes questions
about demographics, treatment experience and arrest history.
For the present study, the SAM was modified to include separate as-
sessment question sets for four “club drugs”: MDMA, Rohypnol, GHB
and ketamine. The SAM drug categories that included prescription
drugs were stimulants, sedatives, and opioids. The analyses of prescrip-
tion drug abuse in this report exclude any street drugs traditionally in-
cluded in these categories (e.g., methamphetamine and khat within
stimulants). Analyses of abuse and dependence criteria of prescription
sedatives were limited because many of these questions were deleted
from the revised SAM in order to ask more questions about club drugs.
Similar analyses related to stimulants were also limited because that
category included a broad array of both prescription and street drugs.
Data Analysis
Data from the interview questionnaires were analyzed using a standard
statistical package. To determine relationships between dichotomous
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dependent and independent variables, two-tailed Pearson chi-square
tests for statistical significance and associated levels of probability (p)
were recorded from contingency table analyses. For continuous inde-
pendent variables, means were compared using one-way ANOVA pro-
cedures. These and other statistics are displayed in the text and tables
that follow.
RESULTS
Demographics and Gender Differences
Demographic characteristics of the sample are found in Table 1. The
ethnic distribution including over 50% Hispanic-identified participants
is reflective of the overall makeup of Miami-Dade County. White/An-
glo respondents are somewhat overrepresented and African-Americans
and -Caribbeans underrepresented compared to the overall population,
although the study sample does seem to fairly represent the observed
makeup of the county’s club culture during the data collection period.
The respondents were well-educated, with over 40% having already at-
tained a two- or four-year college degree; many of the high school grad-
uates were already enrolled or planning to enroll in higher education
programs. Lifetime arrest rates were quite high at over 40%, but males
were almost three times more likely to have been arrested than females.
Because of the relative youthfulness of the sample, current employment
status was largely a function of whether or not the respondent was a stu-
dent. Lifetime attraction to and sexual experience with members of the
same sex was of interest because of the historically heavy involvement
of gay and bisexual men in the local club drug using scenes. Although
females were more than twice as likely as males to report some same-
sex attraction during their lifetime, there was no observed difference
between males and females in having had sex with a same-sex partner.
Alcohol and drug use characteristics are displayed in Table 2. Over-
all, respondents reported very high rates of lifetime use of a wide range
of substances. Prescription sedative abuse was quite common, with al-
most three-quarters (74.1%) reporting more than five times recreational
use of these drugs. Prescription opioids had been abused by more than
half (51%) of participants, but males were twice as likely as females to
report this history. Prescription stimulants, on the other hand, had been
abused by just over 25% of respondents. Over 82% of all respondents
had abused at least one prescription drug.
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In response to questions about specific prescription drugs of abuse in
the past 12 months, alprazolam, oxycodone, hydrocodone, and diaze-
pam were cited most often. Alprazolam and diazepam are anti-anxiety
medications; oxycodone and hydrocodone are opioid analgesics. Oxy-
Contin®, a unique time-release form of oxycodone, was abused by more
than 20% of the sample. Males reported more abuse of every prescrip-
tion drug than females, but these differences reached statistical signifi-
cance only for alprazolam, OxyContin®, and morphine. Males also
Kurtz et al. 7






(N = 143) p*
Age (median = 23)
18-20 27.7 25.0 26.6
21-25 38.6 53.4 44.7
26-30 24.1 18.3 21.7
31-40 9.6 3.3 7.0
Ethnicity
African American/Caribbean 2.4 5.0 3.5
Hispanic 51.8 48.3 50.3
White/Anglo 33.7 35.0 34.3
Other 12.1 11.7 11.9
Highest Education Completed
Less than 12th grade 6.0 1.7 4.2
High school diploma/GED 57.8 50.0 54.5
Associates/Bachelor’s 36.2 48.3 41.3
Any Lifetime Arrest 56.6 20.0 41.3 0.000
Employment Status
Unemployed 19.3 15.0 17.5
Employed 30.1 26.6 28.6
Full-time student 41.0 46.7 43.4
Disabled, other 9.6 11.7 10.5
Any Same-Sex Attraction 16.9 41.7 27.3 0.001
Any Same-Sex Behavior 16.9 23.3 19.6
* Pearson’s chi-square, where p < .10
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(N = 143) p*
Lifetime Use (more than 5 times)
Alcohol 100.0 100.0 100.0
Marijuana 98.8 98.3 98.6
Hallucinogens 84.3 70.0 78.3 0.004
Prescription sedatives† 77.1 70.0 74.1
Cocaine 75.9 63.3 70.6
Prescription opioids† 63.9 33.3 51.0 0.000
Ketamine 47.0 30.0 39.9 0.041
GHB 32.5 18.3 26.6
Prescription stimulants† 30.1 20.0 25.9
Methamphetamine 24.1 18.3 21.7
Heroin 15.7 5.0 11.2 0.046
Any prescription drug† 86.7 76.7 82.5
Any Use in the Last Year†
Alprazolam 65.1 46.7 57.3 0.028
Other oxycodone 42.2 26.7 35.7
Hydrocodone 37.3 25.0 32.2
Diazepam 34.9 23.3 30.1
OxyContin® 31.3 8.3 21.7 0.001
Morphine 13.3 3.3 9.1 0.042
Soma 9.6 5.0 7.7
Mean # of Drug Categories Used 8.3 6.7 7.6 0.000
Took Other Drugs with Ecstasy 43.4 30.0 37.8
Have “risky drug and alcohol
behaviors that need changing” 61.4 26.7 46.9 0.000
Prior Drug Treatment History 37.3 20.0 30.1 0.026
* Pearson’s chi-square, where p < .10
† non-prescribed use
indicated lifetime abuse of more drug categories than females (mean 8.3
vs. 6.7), and were more likely to report having “risky drug and alcohol
behaviors that need changing” as well as prior drug treatment experi-
ence. Polydrug use was very high for both genders, however, including
over 37% of respondents who had taken other drugs together with ec-
stasy.
Risks Associated with Prescription Drug Abuse
Table 3 shows comparisons of demographics, drug and arrest histo-
ries, and mental health measures between ecstasy users who also abused
prescription drugs and those who did not. There were no significant dif-
ferences in the demographics or arrest histories of the two groups, but
Kurtz et al. 9













(N = 143) p*
Demographics
Male 61.0 44.0 58.0
Any same-sex attraction 28.0 24.0 27.3
White/Anglo 35.6 28.0 34.3
Any History of Arrest 43.2 32.0 41.3
Any Drug/Alcohol Treatment 34.7 8.0 30.1 0.008
Have “risky drug and alcohol behaviors
that need changing” 53.4 16.0 46.9 0.001
Have “risky sexual behaviors that need
changing” 25.4 24.0 25.2
Mental Health Measures
Depressed 2 weeks in last year 47.5 28.0 44.1 0.075
Lost interest 2 weeks in last year 53.4 28.0 49.0 0.021
Thought suicide 2 weeks in last year 24.6 4.0 21.0 0.022
CES-D Total Score (means) 15.5 11.0 0.068‡
* Pearson’s chi-square, where p < .10
† non-prescribed use
‡ one-way ANOVA
those who had abused prescription drugs were significantly more likely
to have sought drug and/or alcohol treatment in the past and to report
current “risky drug and alcohol behaviors that need changing.” This
self-perception of risk did not extend to sexual behaviors, however. In
fact, the sample on the whole did not exhibit high levels of sexual risk
taking. Although all participants were sexually experienced, serial mo-
nogamy–including the use of birth control pills but not condoms–was
the most common behavioral pattern (data not shown).
Symptoms of depression and suicidal ideation are also shown on Ta-
ble 3. About half of prescription drug abusers reported feeling de-
pressed (47.5%) or having lost interest in life (53.4%) for two weeks or
more in the past year, compared to just over a quarter (28% on both
measures) of non-prescription abusers. Similarly, the CES-D scores of
prescription drug abusers averaged 4.5 points higher than those of
non-abusers. Although this difference did not quite reach the .05 level
of significance, it is noteworthy that the average CES-D score of pre-
scription drug abusers (15.5) approached the traditional cutoff score
(16.0) on this instrument for reaching a diagnosis of clinical depres-
sion.57
Table 4 displays differences between prescription drug abusers and
non-abusers in onset ages for a wide range of substances. Prescription
drug abusers began using alcohol almost two years earlier, marijuana
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(N = 25) p*
Drug Use History (means)
Alcohol onset age 13.9 15.7 0.006
Marijuana onset age (n = 141) 14.7 17.2 0.000
Hallucinogen onset age (n = 112) 16.9 18.3
Ecstasy onset age 18.6 19.3
Cocaine onset age (n = 101) 18.1 19.3
Earliest onset age of any drug/alcohol 13.2 15.3 0.001
Lifetime # of Drug Categories Used (means) 8.3 4.3 0.000
* one-way ANOVA, where p < .10
† non-prescribed use
2.5 years earlier, and their first use of any psychoactive substance 2.1
years earlier, on average, than other ecstasy users. Onset ages for other
drugs showed similar trends but did not register at the .05 significance
level. Drug involvement of prescription drug abusers was also much
more extensive than others, with the former having used, on average,
more than eight different categories of drugs more than five times life-
time, twice as many categories as their non-prescription abusing coun-
terparts.
Finally, Table 5 examines symptoms of tolerance, withdrawal and
abuse of prescription opioids among the 73 participants who abused
those drugs. As noted earlier, the study questionnaires did not permit
similar analyses of symptoms related to prescription stimulants and sed-
atives. Nonetheless, respondents attributed widespread health problems
Kurtz et al. 11
TABLE 5. Consequences of Prescription Opioid Abuse Among Ecstasy Users







Change in appetite 15.1
Feeling anxious 12.3









Laughing/crying for no reason 12.3
Confusion 9.6
to their abuse of prescription opioids. Over 20% responded positively to
one or more questions about withdrawal symptoms, the most common
of which were tiredness, craving and depression. Over 40% of prescrip-
tion opioid abusers affirmatively answered one or more questions about
physical and psychological problems other than withdrawal symptoms
attributed to their use of those drugs.
DISCUSSION
Limitations
There are two primary limitations to the study. First, the results may
not be generalizable to the total population of ecstasy users in Miami be-
cause of non-random selection. As well, participants who expressed in-
terest in participation may have been especially motivated by the monetary
incentives or by particularly good or detrimental drug use experiences.
The other main limitation is that the study was not specifically designed
to examine questions about prescription drug involvement. As such, it
was not possible for the researchers to examine or compare withdrawal,
dependence and abuse criteria for all prescription drug categories or for
individual prescription drugs. Nevertheless, the study instrumentation
did include numerous questions that enabled the researchers to shed
light on an issue that is absent from the literature. Although numerous
reports of club drug users have raised concerns about polydrug use,
none has provided epidemiologic data on the extent of prescription drug
abuse by club drug users.
Implications
The findings of this study are cause for alarm in terms of the extent,
nature and consequences of prescription drug abuse among a sample of
ecstasy users. The vast majority of ecstasy users had histories of such
abuse, and those who did also had extensive involvements with many
other types of psychoactive substances. The data also show prescription
drug abusers to have become involved with drug use at earlier ages than
their counterparts and more likely to perceive their own drug and alco-
hol use to be problematic. Overall, these findings suggest that prescrip-
tion drugs may be becoming an integral part of a continuing and
expanding pattern of polydrug abuse among young people, occurring
within a larger social environment that has embraced the use of pre-
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scription drugs for an increasingly wide array of physical and emotional
complaints. Although males exhibited somewhat higher rates of pre-
scription drug abuse than females, such abuse patterns do not appear
limited by gender, ethnic or age boundaries.
The correlation of prescription drug abuse with indices of depression
and suicidal ideation is of great concern. As is true of most studies
showing associations between ecstasy use and chronic psychological
problems, the study design employed here does not permit attributions
of causation between these psychological problems and prescription
drug abuse per se. Rather, these data point the way to the need for new
studies that can capture the temporality of psychological problems and
the abuse of different prescription and street drugs. Nevertheless, those
who had abused prescription opioids ascribed a wide array of with-
drawal and physical and psychological health problems to their abuse of
such painkillers.
Future Research Directions
This study represents an exploratory examination of the problem of
prescription drug abuse among an already at-risk population: young
adults who have significant experience with the use of ecstasy. The seri-
ousness of the findings described above points to the need for more tar-
geted and extensive studies of the problem, including larger samples,
the identification of methods of access and ingestion of the drugs, the
meanings attributed to prescription drug abuse experiences, and the
health and social consequences of such abuse.
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